The Latest on IDMP Implementation: How New Standards Are Reshaping Pharmaceutical Operations

In a recent webinar titled "Navigating IDMP Implementation: Strategies for Success" Regulatory Affairs Experts Sowmya Raju and Michiel Stam offered a clear and informative overview. Discussing the essential elements of IDMP standards and their practical implementation through the Product Lifecycle Management (PLM) portal and highlighting their impact on the pharmaceutical industry’s regulatory landscape.

2024-04-30T11:41:11+00:00April 23rd, 2024|

Search Regulatory Dossier Metadata & Content with Ease using PowerSearch™ – A Dossplorer™ Regulatory Submission Management Feature

Search Regulatory Dossier Metadata & Content with Ease using PowerSearch™ - A Dossplorer™ Regulatory Submission Management Feature  Regulatory dossiers contain comprehensive and detailed information about pharmaceutical products. Since they serve as the primary source of truth for regulatory agencies to assess the safety, quality, and efficacy, they play a crucial role in

2024-04-23T09:44:18+00:00April 19th, 2024|

Presentation of QC Samples and their Accuracy and Precision in Regulated Bioanalytical Reports

Exploring Quality Control Samples Quality control (QC) samples are an essential aspect of bioanalysis. When conducting bioanalytical studies, it is critical to ensure the accuracy and precision of the methods used to analyze study samples. One way to achieve this is by using QC samples. Samples of known concentrations or purities are

2024-04-17T12:22:13+00:00April 17th, 2024|

The Synergy Between Regulatory Intelligence and Pharmacovigilance

Ensuring Compliance and Patient Safety In the ever-evolving landscape of life sciences and healthcare, regulatory intelligence (RI) and pharmacovigilance (PV) play critical roles. Companies face multifaceted challenges that span across regulatory compliance, safety monitoring, and strategic decision-making. This is where experts like Celegence and Soterius come into play to bridge the gap

2024-04-10T13:58:54+00:00April 10th, 2024|

FDA Guidance: Navigating Annual Reportable Labeling Changes for Nonprescription Drug Products

Navigating Annual Reportable Labeling Changes for Nonprescription Drug Products: FDA Guidance Explained Introduction In the realm of nonprescription drug products, even minor labeling changes require careful consideration and documentation to ensure regulatory compliance and consumer safety. The Food and Drug Administration (FDA) has released comprehensive guidance to assist applicants of approved new

2024-04-25T11:18:28+00:00April 8th, 2024|

Transform Your Pharmacovigilance Medical Writing

Pharmacovigilance Medical Writing In the dynamic landscape of drug development, meticulous documentation plays a pivotal role in securing regulatory approvals. Regulatory medical writing, a specialized discipline, bridges scientific insights with compliance requirements. Celegence, a leading regulatory affairs consultant, assists pharmaceutical companies in creating robust, submission-ready documents. Global Team of Medical Writing Specialists

2024-03-27T14:57:01+00:00March 27th, 2024|

5 Key Strategies for Ensuring Regulatory Labeling Compliance

The Role of Regulatory Labeling Regulatory labeling regulations play a crucial role in ensuring the safe and effective use of drug products by patients. However, compliance with these regulations can be complex, especially with the introduction of new requirements and updates. Global and Regional Regulatory Labeling Managing global and regional labeling in the

2024-03-20T16:41:04+00:00March 20th, 2024|

6th Annual Life Science Regulatory Intelligence & Strategy Conference

6th Annual Life Science Regulatory Intelligence & Strategy Conference  Celegence invites you to join us for the In-Person 6th Annual Life Science Regulatory Intelligence & Strategy Conference presented by Q1 Productions from April 10-11, 2024, in Baltimore, MD, USA.   This event brings together global intelligence, strategy, policy and legal experts to share

2024-04-25T11:15:43+00:00March 19th, 2024|

Celegence’s Dossplorer is Revolutionizing Regulatory Affairs

Dossplorer - Revolutionizing Regulatory Affairs In the fast-paced world of pharmaceuticals, navigating the complexities of regulatory affairs can be daunting. However, with the right tools and solutions, pharmaceutical companies can streamline their processes, save time, and reduce costs significantly.The RSIDM 2024 forum highlighted a crucial focus on improving and optimizing organizational processes and

2024-03-12T12:06:23+00:00March 11th, 2024|

Webinar – EU Pharmaceutical Reform: Unveiling Draft Legislation Impacts

Webinar - EU Pharmaceutical Reform: Unveiling Draft Legislation Impacts What: Webinar – “EU Pharmaceutical Reform: Unveiling Draft Legislation Impacts” When: Thursday, February 29th, 2024, at 10:00 AM EST Where: Online Event How: Register Here Why: This webinar will explore the context of EU pharmaceutical reform and help identify the main changes when

2024-02-06T18:15:55+00:00February 2nd, 2024|
Go to Top